Does METHYLDOPA Cause Glycosylated haemoglobin increased? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Glycosylated haemoglobin increased have been filed in association with METHYLDOPA (Methyldopa). This represents 0.2% of all adverse event reports for METHYLDOPA.
6
Reports of Glycosylated haemoglobin increased with METHYLDOPA
0.2%
of all METHYLDOPA reports
0
Deaths
4
Hospitalizations
How Dangerous Is Glycosylated haemoglobin increased From METHYLDOPA?
Of the 6 reports, 4 (66.7%) required hospitalization.
Is Glycosylated haemoglobin increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLDOPA. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLDOPA Cause?
Foetal exposure during pregnancy (1,028)
Premature baby (792)
Maternal exposure during pregnancy (623)
Premature delivery (519)
Exposure during pregnancy (502)
Low birth weight baby (350)
Foetal growth restriction (172)
Drug ineffective (162)
Live birth (153)
Off label use (152)
What Other Drugs Cause Glycosylated haemoglobin increased?
DULAGLUTIDE (2,691)
INSULIN GLARGINE (2,649)
INSULIN LISPRO (2,482)
METFORMIN (1,539)
INSULIN HUMAN (1,008)
EXENATIDE (921)
SEMAGLUTIDE (818)
EMPAGLIFLOZIN (743)
TIRZEPATIDE (555)
INSULIN ASPART (550)
Which METHYLDOPA Alternatives Have Lower Glycosylated haemoglobin increased Risk?
METHYLDOPA vs METHYLENE BLUE
METHYLDOPA vs METHYLENEDIOXYPYROVALERONE
METHYLDOPA vs METHYLERGONOVINE
METHYLDOPA vs METHYLNALTREXONE
METHYLDOPA vs METHYLPHENIDATE